Christine Gorjanc

Director at Lodo Therapeutics

Christine Gorjanc provides extensive financial, operational and technology experience to guide Zymergen’s growth. She previously served as the CFO of home automation company, Arlo Technologies, Inc., and CFO of NETGEAR, Inc. and currently sits on the boards at networking and cybersecurity solutions company Juniper Networks and genetic information company Invitae Corporation. She earned a B.A. in accounting with honors from the University of Texas at El Paso and an M.S. in taxation from Golden Gate University.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Lodo Therapeutics

1 followers

Lodo Therapeutics discovers and develops novel therapeutics addressing "undruggable" targets with high unmet need by applying its proprietary platform to tap the vast collections of undiscovered molecules encoded in environmental microbial DNA.


Industries

Employees

11-50

Links